Safety, Tolerability and Pharmacokinetics of MK-4334 in Participants With Alzheimer's Clinical Syndrome on a Stable Dose of Donepezil (MK-4334-005)
Conditions:   Alzheimer's Disease;   Mild Cognitive Impairment Interventions:   Drug: MK-4334;   Drug: Placebo to MK-4334;   Drug: Donepezil Sponsor:   Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2018 Category: Research Source Type: clinical trials

A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers
Conditions:   Cognitive Impairment;   Alzheimer Disease Interventions:   Drug: THN 201;   Drug: Donepezil;   Drug: Placebo Sponsor:   Theranexus Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 8, 2018 Category: Research Source Type: clinical trials